{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10"],"submitter":["Cossart AR"],"pubmed_abstract":["<h4>Background</h4>Direct-to-consumer (DTC) electronic prescription services (EPS) are a novel addition to the Australian healthcare landscape. This study aimed to explore consumers' perceptions on how this model of care supports the delivery of best-practice care.<h4>Method</h4>Focus groups participants were recruited through social media and included adults aged 18 years or older, Queensland (Australia) residents, and interested in DTC EPS. Focus groups were conducted via Zoom<sup>®</sup> and repeated until data saturation. Inductive thematic analysis was undertaken to elicit consumer perception themes from focus group discussions and field notes.<h4>Results</h4>Three focus groups were conducted between July and August 2022 and included 13 participants of which two (15%) had previously used DTC EPS. Four major perception themes were induced: (a) Consumer responsibility. There is an assumed level of consumer health literacy leading to an unacceptable burden of responsibility on the patient; (b) System processes appear to be underdeveloped to support best-practice care; (c) Access to convenient and timely healthcare will be improved for many patients, however, out of pocket expenses may promote inequity; and (d) Service model improvements can address safety and quality concerns including integration of the model within existing national digital health platforms.<h4>Conclusion</h4>Participants believed that DTC EPS was a valuable addition to the Australian health care landscape increasing convenient and timely access to medicines for consumers. Participants were concerned that a heavy reliance on health literacy and underdeveloped system processes may lead to unsafe prescribing."],"journal":["Digital health"],"pagination":["20552076241294184"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11544656"],"repository":["biostudies-literature"],"pubmed_title":["Consumer perceptions of direct-to-consumer electronic prescription services in Queensland, Australia."],"pmcid":["PMC11544656"],"pubmed_authors":["Cossart AR","Kennedy E","Freeman CR","Hillen JB","Yong FR"],"additional_accession":[]},"is_claimable":false,"name":"Consumer perceptions of direct-to-consumer electronic prescription services in Queensland, Australia.","description":"<h4>Background</h4>Direct-to-consumer (DTC) electronic prescription services (EPS) are a novel addition to the Australian healthcare landscape. This study aimed to explore consumers' perceptions on how this model of care supports the delivery of best-practice care.<h4>Method</h4>Focus groups participants were recruited through social media and included adults aged 18 years or older, Queensland (Australia) residents, and interested in DTC EPS. Focus groups were conducted via Zoom<sup>®</sup> and repeated until data saturation. Inductive thematic analysis was undertaken to elicit consumer perception themes from focus group discussions and field notes.<h4>Results</h4>Three focus groups were conducted between July and August 2022 and included 13 participants of which two (15%) had previously used DTC EPS. Four major perception themes were induced: (a) Consumer responsibility. There is an assumed level of consumer health literacy leading to an unacceptable burden of responsibility on the patient; (b) System processes appear to be underdeveloped to support best-practice care; (c) Access to convenient and timely healthcare will be improved for many patients, however, out of pocket expenses may promote inequity; and (d) Service model improvements can address safety and quality concerns including integration of the model within existing national digital health platforms.<h4>Conclusion</h4>Participants believed that DTC EPS was a valuable addition to the Australian health care landscape increasing convenient and timely access to medicines for consumers. Participants were concerned that a heavy reliance on health literacy and underdeveloped system processes may lead to unsafe prescribing.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jan-Dec","modification":"2025-04-22T16:07:46.453Z","creation":"2025-04-06T01:42:32.503Z"},"accession":"S-EPMC11544656","cross_references":{"pubmed":["39525558"],"doi":["10.1177/20552076241294184"]}}